- Products
- Reproduction
- Molecular diagnostics
- Careers
- About us
- Contacts
A liquid biopsy company that is revolutionizing cancer treatment by detecting the disease earlier, at a time when intervention can have the greatest impact for patients. Our pioneering approach to testing uses methylation-based identification of epigenetic changes for early detection of bladder and lung cancer.
